300149 睿智医药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资200,4831.51%197,494197,018175,964153,244
投资性房地产76,199-3.80%79,21214,18549,85753,577
固定资产355,599-4.90%373,936374,538671,077637,346
在建工程11,08339.18%7,96375,358235,735308,785
无形资产30,5661.72%30,04855,656148,610165,001
商誉164,0300.00%164,030858,8601,207,4591,575,059
其他非流动资产826,601-5.99%879,231967,9231,041,144308,689
1,664,562-3.89%1,731,9142,543,5383,529,8473,201,702

流动资产
货币资金317,152-8.67%347,260761,664160,460259,121
应收账款190,427-27.83%263,853341,495335,166384,471
存货17,179-38.39%27,88242,81768,81254,807
其他流动资产90,2982.40%88,185134,384123,307221,480
615,056-15.42%727,1791,280,359687,745919,879

流动负债
短期借款38,469-35.89%60,003115,023158,566112,500
应付票据0--0002,931
应付帐款43,471-19.19%53,79280,698108,37877,236
其他流动负债278,524-11.01%312,980536,310723,714594,932
360,464-15.54%426,775732,031990,657787,600
流动资产净值254,592-15.25%300,404548,328(302,913)132,279
资产总额减流动负债1,919,154-5.57%2,032,3183,091,8663,226,9343,333,981

非流动负债
长期借款40,415-7.46%43,675177,210614,918792,133
应付债券0--0000
其他非流动负债457,208-9.10%502,988528,695622,93989,460
497,623-8.97%546,663705,9051,237,857881,593

总权益
    实收股本499,7770.00%499,777499,777499,777499,777
    储备项目897,588-6.66%961,6401,861,7591,464,6681,928,127
股东权益1,397,365-4.38%1,461,4172,361,5361,964,4452,427,904
非控股权益24,165-0.31%24,23924,42524,63224,484